IRWD
Price:
$4.51
Market Cap:
$720.42M
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary ch...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2010-02-03
Stock Exchange
NASDAQ
Ticker
IRWD
According to Ironwood Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -2.78%. This represents a change of 288.65% compared to the average of -0.72% of the last 4 quarters.
The mean historical ROE of Ironwood Pharmaceuticals, Inc. over the last ten years is -94.08%. The current -2.78% ROE has changed -97.04% with respect to the historical average. Over the past ten years (40 quarters), IRWD's ROE was at its highest in in the September 2020 quarter at 583.05%. The ROE was at its lowest in in the June 2017 quarter at -908.09%.
Average
-94.08%
Median
21.63%
Minimum
-1187.42%
Maximum
289.42%
Discovering the peaks and valleys of Ironwood Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 978.51%
Maximum Annual ROE = 289.42%
Minimum Annual Increase = -112.11%
Minimum Annual ROE = -1187.42%
Year | ROE | Change |
---|---|---|
2023 | 289.42% | 978.51% |
2022 | 26.83% | -69.23% |
2021 | 87.22% | -48.55% |
2020 | 169.50% | 932.14% |
2019 | 16.42% | -88.58% |
2018 | 143.79% | -112.11% |
2017 | -1187.42% | 869.55% |
2016 | -122.47% | -18.34% |
2015 | -149.98% | -29.96% |
2014 | -214.13% | -70.00% |
The current ROE of Ironwood Pharmaceuticals, Inc. (IRWD) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
134.49%
5-year avg
117.88%
10-year avg
-94.08%
Ironwood Pharmaceuticals, Inc.’s ROE is less than Neurocrine Biosciences, Inc. (14.86%), less than Amphastar Pharmaceuticals, Inc. (25.42%), less than Collegium Pharmaceutical, Inc. (49.14%), less than ANI Pharmaceuticals, Inc. (6.02%), less than Alkermes plc (22.66%), greater than Intra-Cellular Therapies, Inc. (-11.48%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), less than Pacira BioSciences, Inc. (7.32%), greater than Avadel Pharmaceuticals plc (-122.60%), less than Eagle Pharmaceuticals, Inc. (4.41%), greater than Assertio Holdings, Inc. (-231.03%), less than Esperion Therapeutics, Inc. (26.20%),
Company | ROE | Market cap |
---|---|---|
14.86% | $12.13B | |
25.42% | $2.21B | |
49.14% | $1.20B | |
6.02% | $1.27B | |
22.66% | $4.42B | |
-11.48% | $7.77B | |
-52.42% | $2.21B | |
7.32% | $638.86M | |
-122.60% | $1.39B | |
4.41% | $55.19M | |
-231.03% | $120.12M | |
26.20% | $323.77M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ironwood Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ironwood Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ironwood Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for Ironwood Pharmaceuticals, Inc. (IRWD)?
What is the highest ROE for Ironwood Pharmaceuticals, Inc. (IRWD)?
What is the 3-year average ROE for Ironwood Pharmaceuticals, Inc. (IRWD)?
What is the 5-year average ROE for Ironwood Pharmaceuticals, Inc. (IRWD)?
How does the current ROE for Ironwood Pharmaceuticals, Inc. (IRWD) compare to its historical average?